Long-term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30-month analysis of the randomized phase 2 BOLT study-Reference-Cited by-同舟云学术

Long-term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30-month analysis of the randomized phase 2 BOLT study

Published:2017-11-06 Issue:3 Volume:32 Page:372-381
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:J Eur Acad Dermatol Venereol

Author:

Lear J.T.¹,Migden M.R.²,Lewis K.D.³,Chang A.L.S.⁴,Guminski A.⁵,Gutzmer R.⁶,Dirix L.⁷,Combemale P.⁸,Stratigos A.⁹,Plummer R.¹⁰,Castro H.¹¹,Yi T.¹²,Mone M.¹²,Zhou J.¹²,Trefzer U.¹³,Kaatz M.¹⁴,Loquai C.¹⁵,Kudchadkar R.¹⁶,Sellami D.¹²,Dummer R.¹⁷

Affiliation:

1. Manchester Academic Health Science Centre; University of Manchester; Manchester UK

2. Departments of Dermatology and Head and Neck Surgery; The University of Texas MD Anderson Cancer Center; Houston TX USA

3. Division of Medical Oncology; University of Colorado School of Medicine; Aurora CO USA

4. Stanford University School of Medicine; Redwood City CA USA

5. Royal North Shore Hospital; St Leonards NSW Australia

6. Medizinische Hochschule Hannover; Hannover Germany

7. Sint-Augustinus Ziekenhuis; Antwerp Belgium

8. Anti Cancer Institute, Léon Bérard; Lyon France

9. Andreas Syggros Hospital; University of Athens; Athens Greece

10. Northern Centre for Cancer Care; Freeman Hospital; Newcastle upon Tyne UK

11. Novartis Pharma AG; Basel Switzerland

12. Novartis Pharmaceuticals Corporation; East Hanover NJ USA

13. Dermatologikum Berlin; Berlin Germany

14. University Hospital Jena; Jena Germany

15. University Medical Center Mainz; Mainz Germany

16. Winship Cancer Institute of Emory University; Atlanta GA USA

17. UniversitätsSpital Zürich-Skin Cancer Center; University Hospital; Zürich Switzerland

Funder

Novartis Pharmaceuticals Corporation

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jdv.14542/fullpdf

Reference39 articles.

1. Challenges and new horizons in the management of advanced basal cell carcinoma: a UK perspective;Lear;Br J Cancer,2014

2. Basal cell carcinoma;Wong;BMJ,2003

3. Non-melanoma skin cancer;Madan;Lancet,2010

4. Targeting the Hedgehog pathway in cancer;Gupta;Ther Adv Med Oncol,2010

5. Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas;Reifenberger;Br J Dermatol,2005

Cited by 157 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-Risk Non-Melanoma Skin Cancers;Hematology/Oncology Clinics of North America;2024-10

2. Therapeutic Advances in Advanced Basal Cell Carcinoma;Cancers;2024-09-04

3. Images in Immunotherapy and Precision Oncology: Advanced Basal Cell Carcinoma;Journal of Immunotherapy and Precision Oncology;2024-08-01

4. Emerging Indications for Neoadjuvant Systemic Therapies in Cutaneous Malignancies;Medical Sciences;2024-07-23

5. Survey of the impact of BOLT-trial data on oncologists’ and dermatologists’ decision-making in treating patients with locally advanced basal cell carcinoma;Dermatology Reports;2024-07-03